Full Press Release Details
New Data at AAN Showcase Biogen’s Commitment to Advancing Innovation in MS.
BIIB
New Data at AAN Showcase Biogen’s Commitment to Advancing Innovation in MS
Key Takeaway: New Data at AAN Showcase Biogen’s Commitment to Advancing Innovation in MS
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis